ELC-100

N/A

Report date: 2025/06/03 13:55:36

Base Information

Drug NameELC-100
Drug Alias NameAd5PTDCgA-E1AmiR122Ad5-PTD-CgA-E1A-miR122AdVinceAdVince +[6
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionImmunologic cytotoxicity
TargetsNot applicable
Therapy Area/IndicationsNeuroendocrine Tumors
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUppsala Universitet
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNeuroendocrine Tumors
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A